Published Manuscript Questions Risk-to-Benefit Ratio of COVID-19 Boosters in Immunocompromised
Milder Strains, Natural Immunity, and Unfavorable Trends for Recurrent COVID-19 in Vaccinated Turns the Tide Against Continued Boosters
By Peter A. McCullough, MD, MPH
One of the most visible categories of immunocompromised patients we have in clinical practice are those who have undergone organ transplantation, most commonly kidney and heart. A new analysis published suggests that continued boosters are weakening the immunity of those on immunosuppressives and thus allowing more not less COVID-19 infections. Boretti, from the Melbourne Institute of Technology, makes these observations:
“A considerable body of evidence indicates a correlation, and some recent studies even suggest causation, highlighting the potential for mRNA COVID-19 boosters to have adverse effects on the immune system. This is particularly relevant in the case of immunocompromised individuals, where the overall cost-to-benefit ratio may lean toward the negative. A comprehensive, evidence-based assessment is essential to promptly evaluate the implications of continuous COVID-19 vaccine booster use for this specific population. Given the decreased severity of the virus, as acknowledged in various jurisdictions, there are legitimate concerns about the frequent administration of boosters in immunocompromised patients, raising questions about whether this practice may be causing more harm than benefit.”
The manuscript does not address safety, however, as I point out in this recent vertical short video, injection of genetic code and then long-lasting expression of a foreign protein within tissues including the organ for or received for transplantation is a disastrous idea.
Simply put, COVID-19 genetic vaccination is an invitation for transplant organ failure. Transplant programs that have been unbridled institutional zealots for novel genetic vaccination without long-term safety data or convincing randomized trial results on hard primary outcomes will have to come to grips with reality as more questions and poor results are returned.
Subscribe to Courageous Discourse as a paying or founder member so we can continue to bring you the truth at a time when you need it the most.
Peter A. McCullough, MD, MPH
President, McCullough Foundation
Considering that transplant patients ALREADY take medication (tacrolimus, etc.) that suppresses the immune system, to then inject these patients with something that even further depletes their immune system is totally irrational.
Many transplant candidates have been turned down if they OR a family member refused the COVID jab. Many lives lost for this reason.